The new medicines for the control of diabetes and obesity, also known as ‘Ozempic type’ drugs, or GLP-1 agonists, have been associated with a reduction in the risk of developing different cardiovascular and kidney diseases, among others. Now, a study conducted by experts from Johns Hopkins University (Baltimore, States ... Continue reading “Discard that using Ozempic influences the risk of degenerative eye disease”
The new medicines for the control of diabetes and obesity, also known as ‘Ozempic type’ drugs, or GLP-1 agonists, have been associated with a reduction in the risk of developing different cardiovascular and kidney diseases, among others. Now, a study conducted by experts from Johns Hopkins University (Baltimore, States ... Continue reading “Discard that using Ozempic influences the risk of degenerative eye disease”